Abstract
The pharmacokinetics of amikacin in 10 patients with hematologic malignancies and 1 patient with aplastic anemia were investigated. At an administered dose of 7 mg/kg of body weight, a volume of distribution of 0.4 liters/kg, an elimination half-life of 3.0 h, and a total body clearance of 2.1 ml/min per kg, amikacin achieved a peak level in blood of 21 micrograms/ml. Results of the study revealed that there was a marked increase in volume of distribution of amikacin in these patients compared with normal.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Anderson E. T., Young L. S., Hewitt W. L. Simultaneous antibiotic levels in "breakthrough" gram-negative rod bacteremia. Am J Med. 1976 Oct;61(4):493–497. doi: 10.1016/0002-9343(76)90328-4. [DOI] [PubMed] [Google Scholar]
- Clarke J. T., Libke R. D., Regamey C., Kirby W. M. Comparative pharmacokinetics of amikacin and kanamycin. Clin Pharmacol Ther. 1974 Jun;15(6):610–616. doi: 10.1002/cpt1974156610. [DOI] [PubMed] [Google Scholar]
- Cockcroft D. W., Gault M. H. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31–41. doi: 10.1159/000180580. [DOI] [PubMed] [Google Scholar]
- Höffler D., Koeppe P., Demers H. G. Pharmacokinetics of amikacin for treatment of urinary tract infections in patients with reduced renal function. J Infect Dis. 1976 Nov;134(Suppl):S369–S373. doi: 10.1093/infdis/135.supplement_2.s369. [DOI] [PubMed] [Google Scholar]
- Kirby W. M., Clarke J. T., Libke R. D., Regamey C. Clinical pharmacology of amikacin and kanamycin. J Infect Dis. 1976 Nov;134(Suppl):S312–S315. doi: 10.1093/infdis/135.supplement_2.s312. [DOI] [PubMed] [Google Scholar]
- Kramer W. G., Cleary T., Frankel L. S., Kohl S., Pickering L. K. Multiple-dose amikacin kinetics in pediatric oncology patients. Clin Pharmacol Ther. 1979 Nov;26(5):635–640. doi: 10.1002/cpt1979265635. [DOI] [PubMed] [Google Scholar]
- Lode H., Grunert K., Koeppe P., Langmaack H. Pharmacokinetic and clinical studies with amikacin, a new aminoglycoside antibiotic. J Infect Dis. 1976 Nov;134(Suppl):S316–S322. doi: 10.1093/infdis/135.supplement_2.s316. [DOI] [PubMed] [Google Scholar]
- Manny R. P., Hutson P. R. Aminoglycoside volume of distribution in hematology-oncology patients. Clin Pharm. 1986 Aug;5(8):629–632. [PubMed] [Google Scholar]
- Moore R. D., Smith C. R., Lietman P. S. The association of aminoglycoside plasma levels with mortality in patients with gram-negative bacteremia. J Infect Dis. 1984 Mar;149(3):443–448. doi: 10.1093/infdis/149.3.443. [DOI] [PubMed] [Google Scholar]
- Noone P., Parsons T. M., Pattison J. R., Slack R. C., Garfield-Davies D., Hughes K. Experience in monitoring gentamicin therapy during treatment of serious gram-negative sepsis. Br Med J. 1974 Mar 16;1(5906):477–481. doi: 10.1136/bmj.1.5906.477. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Plantier J., Forrey A. W., O'Neill M. A., Blair A. D., Christopher T. G., Cutler R. E. Pharmacokinetics of amikacin in patients with normal or impaired renal function: radioenzymatic acetylation assay. J Infect Dis. 1976 Nov;134(Suppl):S323–S330. doi: 10.1093/infdis/135.supplement_2.s323. [DOI] [PubMed] [Google Scholar]
- Sarubbi F. A., Jr, Hull J. H. Amikacin serum concentrations: prediction of levels and dosage guidelines. Ann Intern Med. 1978 Nov;89(5 Pt 1):612–618. doi: 10.7326/0003-4819-89-5-612. [DOI] [PubMed] [Google Scholar]
- Vogelstein B., Kowarski A., Lietman P. S. The pharmacokinetics of amikacin in children. J Pediatr. 1977 Aug;91(2):333–339. doi: 10.1016/s0022-3476(77)80847-0. [DOI] [PubMed] [Google Scholar]